GHRP-2: What the Research Actually Says About This Peptide
What Is GHRP-2?
GHRP-2 stands for Growth Hormone-Releasing Peptide 2. It is also known by its clinical name pralmorelin. Think of it as a tiny key — just a handful of amino acids (the building blocks of proteins) — engineered to fit a very specific lock in your body.[1]
That lock is called the ghrelin receptor, or GHS-R. Ghrelin is your body's natural "hunger signal" hormone, produced mainly in the stomach. GHRP-2 mimics ghrelin's actions, which means it can trigger two big effects: a surge in growth hormone (GH) release from the pituitary gland, and a boost in appetite.[1]
It was originally developed by researchers at Tulane University and can be given in several ways — under the skin, by mouth, or even nasally.[1] It is strictly a research compound, not an approved treatment in most countries.
How Does GHRP-2 Actually Work?
Your pituitary gland — a pea-sized gland at the base of your brain — controls how much growth hormone enters your bloodstream. GHRP-2 acts directly on this gland to trigger a GH pulse. Importantly, studies confirm it does not work through the growth hormone-releasing factor (GRF) receptor, meaning it uses its own separate pathway.[5] This makes it scientifically useful for teasing apart different hormonal systems.
What Is Research Studying GHRP-2 For?
1. Diagnosing Growth Hormone Deficiency
One of the most developed clinical uses is as a diagnostic tool. Because GHRP-2 reliably spikes GH levels in healthy people but produces a much smaller response in those with GH deficiency, doctors can use it as a test. Research established a cut-off GH peak of 15.0 micrograms per litre to help tell apart deficient patients from healthy ones.[1] In Japan, it has been evaluated for approval as a diagnostic agent under the name KP-102D.[1]
2. Appetite and Food Intake
Because GHRP-2 activates the same receptor as ghrelin — the hunger hormone — scientists tested whether it could increase eating in humans. In a controlled study, seven healthy lean men received a slow infusion of GHRP-2 or a salt-water placebo. The result? Every single participant ate more on the GHRP-2 day — on average 36% more calories compared to the placebo day.[2] The type of food they chose (carbs, fat, protein) did not change, just the total amount. This makes GHRP-2 a useful research tool for studying hunger signals in humans.[2]
3. Muscle Protection
Muscle wasting is a serious problem in illness and after steroid treatments. Lab research looked at whether GHRP-2 could protect muscle cells. In rat muscle and in isolated muscle cell cultures, GHRP-2 reduced the activity of two proteins — Atrogin-1 and MuRF1 — that normally tag muscle for breakdown.[4] When researchers blocked the ghrelin receptor with a chemical blocker, this protective effect disappeared, confirming GHRP-2 works through that receptor.[4] This is early-stage, preclinical work, but it points to an interesting avenue for future research.
Anti-Doping: Why Athletes Are Tested for It
Because GHRP-2 can raise growth hormone levels, the World Anti-Doping Agency (WADA) has placed it on its Prohibited List. Sports testing laboratories have developed urine tests that can detect GHRP-2 and its breakdown products in athlete samples.[3] After nasal administration in one study, GHRP-2 and its metabolites were detectable in urine for up to 47 hours.[6] Detection windows can vary depending on how it is taken and individual metabolism.[6]
What the Evidence Does — and Doesn't — Show
The research is genuinely interesting, but it is important to be clear about its limits:
- Human appetite data comes from a small study of just seven men.[2] Larger trials are needed.
- Muscle protection findings are from rat and cell-culture experiments — not human clinical trials.[4]
- Diagnostic use is the most clinically developed application, with phase II trials conducted in Japan.[1]
- None of this constitutes medical advice, and GHRP-2 is not an approved drug for general use.
Where to Find Dosage Information and Tools
If you are a researcher or simply curious about the numbers used in published studies, our GHRP-2 dosage chart summarises the amounts reported in the scientific literature. You can also use our calculator to explore research-based figures. All information on this site is for educational purposes only.
Sources
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. — Drugs in R&D, 2004. PMID 15230633.
- Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. — The Journal of clinical endocrinology and metabolism, 2005. PMID 15699539.
- Detection of GHRP-2 and GHRP-6 in urine samples from athletes. — Drug testing and analysis, 2015. PMID 25809000.
- GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. — Life sciences, 2008. PMID 18191156.
- Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells. — Endocrine, 1998. PMID 9798733.
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. — Drug testing and analysis, 2015. PMID 25869809.